StockData
HeartBeam, Inc. logo

HeartBeam, Inc. (BEAT) stock

BEATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BEATW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$0.55+0.01 (+2.06%)

Close on Oct 30, 2026Market cap $659.29KP/E –Yield –

HeartBeam operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

HeartBeam's operating income for the twelve months ending Jun 30, 2026 was -$20.41M. For fiscal 2025 it was -$21.14M. The highest annual figure on record is -$788.00K in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.14M–
FY2024Dec 31, 2024-$19.89M–
FY2023Dec 31, 2023-$15.31M–
FY2022Dec 31, 2022-$13.03M–
FY2021Dec 31, 2021-$2.29M–
FY2020Dec 31, 2020-$788.00K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.09M–
Q1 FY2026Mar 31, 2026-$4.72M–
Q4 FY2025Dec 31, 2025-$5.31M–
Q3 FY2025Sep 30, 2025-$5.29M–
Q2 FY2025Jun 30, 2025-$5.04M–
Q1 FY2025Mar 31, 2025-$5.50M–
Q4 FY2024Dec 31, 2024-$4.94M–
Q3 FY2024Sep 30, 2024-$5.07M–
Q2 FY2024Jun 30, 2024-$5.09M–
Q1 FY2024Mar 31, 2024-$4.78M–
Q4 FY2023Dec 31, 2023-$4.11M–
Q3 FY2023Sep 30, 2023-$3.74M–
Q2 FY2023Jun 30, 2023-$3.31M–
Q1 FY2023Mar 31, 2023-$4.16M–
Q4 FY2022Dec 31, 2022-$3.74M–
Q3 FY2022Sep 30, 2022-$3.61M–
Q2 FY2022Jun 30, 2022-$3.54M–
Q1 FY2022Mar 31, 2022-$2.15M–
Q4 FY2021Dec 31, 2021-$1.34M–
Q3 FY2021Sep 30, 2021-$446.00K–
Q2 FY2021Jun 30, 2021-$337.00K–
Q1 FY2021Mar 31, 2021-$163.00K–
Q4 FY2020Dec 31, 2020-$261.00K–
Q3 FY2020Sep 30, 2020-$272.00K–

More HeartBeam figures